Real-world Outcomes and Factors Predicting Survival and Completion of Radium 223 in Metastatic Castrate-resistant Prostate Cancer

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

Chris Parker, Sten Nilsson, Daniel Heinrich et al. · New England Journal of Medicine · 2013 · 3.3K citations

Medicine, Nuclear Medicine, Radiation Oncology +17

Prognostic Importance of Comorbidity in a Hospital-Based Cancer Registry

Jay F. Piccirillo · JAMA · 2004 · 1.2K citations

Medicine, Oncology, Cancer Control +16

Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use

David Lorente, Joaquı́n Mateo, Arnoud J. Templeton et al. · Annals of Oncology · 2014 · 194 citations · Full text

Medicine, Oncology, Chemotherapy +6

Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease

Michael R. Harrison, Daniel J. George, Wong et al. · Cancer Management and Research · 2013 · 114 citations · Full text

Medicine, Oncology, Pharmacology +17

Factors affecting 223Ra therapy: clinical experience after 532 cycles from a single institution

Elba Etchebehere, Denái R. Milton, John C. Araujo et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 57 citations

Medicine, Oncology, Radiation Oncology +9